Information was received from a healthcare provider (hcp) via a clinical study regarding a patient receiving morphine (2.0 mg/ml at 0.7491 mg/day) and bupivacaine (20.0 mg/ml at 7.491 mg/day) via an implantable infusion pump.The indication for use was noted as non-malignant pain.It was reported the patient was feeling "loopy", dizzy, confused, and had experienced a couple falling episodes beginning on (b)(6).The clinical diagnosis was listed as it medication side effects.It was indicated the event was possibly related to the device or therapy and possibly related to the drug morphine.On (b)(6), the patient presented to the clinic and the it rate was decreased, as the provider indicated the if the patient had only minimal pain, they might be receiving too much medication the issue resolved without sequelae on (b)(6).
|